Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Gmo Product Platform's Debt-to-Equity or its related term are showing as below:
TSE:3695'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.01 Max: 0.36
Current: 0.36
During the past 13 years, the highest Debt-to-Equity Ratio of Gmo Product Platform was 0.36. The lowest was 0.00. And the median was 0.01.
TSE:3695's Debt-to-Equity is ranked worse than 62.8% of 2239
companies
in the Software industry
Industry Median: 0.2
vs TSE:3695: 0.36
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Gmo Product Platform Debt-to-Equity Related Terms
Gmo Product Platform Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Gmo Product Platform's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3695 vs MSFT, PLTR, ORCL: Debt-to-Equity Comparison
For the Software - Infrastructure subindustry, Gmo Product Platform's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gmo Product Platform Debt-to-Equity vs Software Industry
For the Software industry and Technology sector, Gmo Product Platform's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Gmo Product Platform's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gmo Product Platform (TSE:3695) has a Debt-to-Equity of 0.36 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Gmo Product Platform and its competitors. This is 3500% above median its historical median of 0.01. According to the industry distribution chart, Gmo Product Platform ranks #1406 out of 2239 companies in the Software industry, placing it in the top 62.8%.
Is Gmo Product Platform's Debt-to-Equity too high?
Gmo Product Platform's current Debt-to-Equity of 0.36 is 3500% above median its 10-year median of 0.01. The Software industry median Debt-to-Equity is 0.20. Gmo Product Platform's value of 0.36 is 80% above this industry median. Based on the distribution chart, Gmo Product Platform ranks #1406 out of 2239 companies in the Software industry, which is below the industry midpoint. Overall, Gmo Product Platform has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gmo Product Platform's Debt-to-Equity compare to MSFT and PLTR?
According to the Software industry distribution chart, Gmo Product Platform ranks #1406 out of 2239 companies for Debt-to-Equity. This places Gmo Product Platform in the lower half of its industry. The industry median Debt-to-Equity is 0.20. Gmo Product Platform's value of 0.36 is 80% above this benchmark. While the company's 10-year median is 0.01 vs. the industry median of 0.20, Gmo Product Platform has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Software company?
The median Debt-to-Equity among Software companies is 0.20, based on 2,239 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gmo Product Platform's current Debt-to-Equity of 0.36 is 80% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Gmo Product Platform and its competitors. For the Software industry, the median Debt-to-Equity is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gmo Product Platform's current Debt-to-Equity is 0.36, which is 3500% above median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gmo Product Platform stock overvalued right now?
Based on GuruFocus' analysis, Gmo Product Platform (TSE:3695) is currently considered Fairly Valued. The stock's GF Value™ is 円1,580.11, compared to a current price of 円1,650.00 — trading 4.4% above its estimated fair value. The current Debt-to-Equity is 0.36, which is 3500% above median its 10-year median of 0.01 and 80% above the Software industry median of 0.20. Gmo Product Platform's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Gmo Product Platform (TSE:3695), the current Debt-to-Equity is 0.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gmo Product Platform (TSE:3695) Overvalued in 2026?
Based on GuruFocus' analysis, Gmo Product Platform stock appears to be overvalued.
The current stock price of 円1,650.00 is trading 4.4% above its estimated GF Value™ of 円1,580.11.
GuruFocus considers Gmo Product Platform to be Fairly Valued.
Key valuation signals for TSE:3695:
Debt-to-Equity: 0.36 (3500% above median its 10-year median of 0.01)
GF Value™: 円1,580.11 vs. price of 円1,650.00 (4.4% above fair value)
Industry Position: 80% above the Software median (#1406 of 2239)
No single metric tells the full story. See the TSE:3695 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gmo Product Platform Inc offers online payment and business-to-business payment platform services that help startups, tech companies, and SMEs improve payment processing and operational efficiency. The solutions of the company support various business models with digital payment infrastructure and finance-related services.
71GF Score
Get the complete analysis for TSE:3695
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3695 has been successfully added to your 
